Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/14/2003 | US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/14/2003 | US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture |
08/14/2003 | US20030152973 G-protein coupled receptor org3 |
08/14/2003 | US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
08/14/2003 | US20030152953 Polynucleotide encoding a novel human potassium channel alpha-subunit, K+alphaM2 |
08/14/2003 | US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
08/14/2003 | US20030152947 Methods for detecting and treating the early onset of aging-related conditions |
08/14/2003 | US20030152935 Comprises hybridization probes; electrophoresis; drug screening |
08/14/2003 | US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/14/2003 | US20030152915 Recombinant Hepatitis C virus RNA replicase |
08/14/2003 | US20030152913 High throughput screening of antibody libraries against membrane proteins; chemokines; infection inhibition |
08/14/2003 | US20030152912 Multiple viral replicon culture systems |
08/14/2003 | US20030152909 Tissue/organ models; improved storage stability; drug screening |
08/14/2003 | US20030152571 Anti-alphabeta3 humanized monoclonal antibodies |
08/14/2003 | US20030152563 Administering plasminogen activator; biocompatiblity coupling to red blood carrier; drug delivery |
08/14/2003 | US20030152562 Diffusion of gases, nutrients into micro-organs; culture; cell proliferation |
08/14/2003 | US20030152561 Diffusion of gases, nutrients into micro-organs; culture; cell proliferation |
08/14/2003 | US20030152560 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy |
08/14/2003 | US20030152559 Infecting bone marrow cells; anticancer agents; inducing immunology response; viricides, antiallergens, autoimmune disease |
08/14/2003 | US20030152558 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
08/14/2003 | US20030152556 Fabrication of a cartilage implant |
08/14/2003 | US20030152551 2-Methyl-3-butenyl-1-pyrophosphoric acid salt and agent for treating lymphocytes |
08/14/2003 | US20030152550 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
08/14/2003 | US20030152549 Methods and apparatus for cell based screening |
08/14/2003 | US20030152526 Bovine milk growth factor |
08/14/2003 | CA2485064A1 Albumin-fused kunitz domain peptides |
08/14/2003 | CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations |
08/14/2003 | CA2476275A1 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate cns nerve regeneration |
08/14/2003 | CA2476214A1 Proliferated cell lines and uses thereof |
08/14/2003 | CA2475539A1 Hiv inhibiting proteins |
08/14/2003 | CA2475382A1 Albumin-fused anti-angiogenesis peptides |
08/14/2003 | CA2475329A1 Truncated aggrecanase molecules |
08/14/2003 | CA2475326A1 A continuous cell line for the production of vaccines |
08/14/2003 | CA2475288A1 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
08/14/2003 | CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system |
08/14/2003 | CA2475095A1 Degradation of hydrophobic ester pesticides and toxins |
08/14/2003 | CA2475055A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
08/14/2003 | CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
08/14/2003 | CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
08/14/2003 | CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
08/14/2003 | CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders |
08/14/2003 | CA2473182A1 Compositions and methods for treatment of vitamin d deficiency |
08/14/2003 | CA2467893A1 Modified antigen-presenting cells |
08/14/2003 | CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use |
08/14/2003 | CA2459718A1 Thermus scotoductus nucleic acid polymerases |
08/13/2003 | EP1335022A1 Modification of plant cell wall component and method of regulating development differentiation |
08/13/2003 | EP1335019A1 T cell line and use thereof |
08/13/2003 | EP1335018A1 Sericin-containing material, process for producing the same and method of using the same |
08/13/2003 | EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
08/13/2003 | EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII |
08/13/2003 | EP1334982A2 Solubilized complement receptor type 1 in crystal form |
08/13/2003 | EP1334980A1 Multimerized highly functional antifreeze protein |
08/13/2003 | EP1334979A1 Gene conferring resistance to Phytophthera infestans (late-blight) in Solanaceae |
08/13/2003 | EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
08/13/2003 | EP1334201A2 Dna expression vectors |
08/13/2003 | EP1334200A2 Multiple inducible gene regulation system |
08/13/2003 | EP1334194A2 Imaging, diagnosis and treatment of disease |
08/13/2003 | EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
08/13/2003 | EP1334192A2 Cystoskeleton-associated proteins |
08/13/2003 | EP1334188A2 Cd19-specific redirected immune cells |
08/13/2003 | EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
08/13/2003 | EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
08/13/2003 | EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
08/13/2003 | EP1334179A2 A human serpin secreted from lymphoid cells lsi-01 |
08/13/2003 | EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain |
08/13/2003 | EP1334177A1 Generation and use of dendritic cells |
08/13/2003 | EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
08/13/2003 | EP1334126A1 Human stra6-like protein and nucleic acids encoding the same |
08/13/2003 | EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
08/13/2003 | EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins |
08/13/2003 | EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems |
08/13/2003 | EP1334112A2 Cell lines expressing a mch receptor |
08/13/2003 | EP1333863A2 Vector system for transducing th positive neurons |
08/13/2003 | EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
08/13/2003 | EP1333853A1 Growth factor complex |
08/13/2003 | EP1333846A1 Preparation and xenotransplantation or porcine islets |
08/13/2003 | EP1333845A1 Treatment of t cell disorders |
08/13/2003 | EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation |
08/13/2003 | EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
08/13/2003 | EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
08/13/2003 | EP1066060B1 Mesenchymal stem cells as immunosuppressants |
08/13/2003 | EP0989859B1 Cns neuroregenerative compositions and methods of use |
08/13/2003 | EP0695361B1 Expression of heterologous genes according to a targeted expression profile |
08/13/2003 | EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide |
08/13/2003 | EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
08/13/2003 | EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals |
08/13/2003 | EP0531472B1 Humanized monoclonal antibodies |
08/13/2003 | CN1436241A Sphingosine kinase and uses thereof |
08/13/2003 | CN1436239A Novel enzyme gene and its expression product |
08/13/2003 | CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
08/13/2003 | CN1436236A Gasci基因 Gasci gene |
08/13/2003 | CN1436235A Anti-angiogenic polypeptides |
08/13/2003 | CN1436234A Composition and methods for therapy and diagnosis of prostate cancer |
08/13/2003 | CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity |
08/13/2003 | CN1435187A Neural stem cell preparation, preparing method thereof and use of same |
08/13/2003 | CN1117866C Method of introducing predetermined alteration in target sequence of genome of cell having nucleus |
08/13/2003 | CN1117864C Production of gamma linolenic acid by delta 6-desaturase |
08/13/2003 | CN1117858C Hepatitis B virus core gene and fore S1 area gene transfected mouse target cell line and use thereof |
08/13/2003 | CN1117857C Tissue culture method for breeding aloe and culture medium therefor |
08/13/2003 | CN1117763C Anti-alphaV-integrin monoclonal antibody |